Clin2
NCT06938750Possibly a fitRecruiting

New device study for ICU drug delivery

Vascular AccessVascular Access ComplicationVascular Access ComplicationsCatheter MalfunctionCatheter InfectionTherapeutic Drug ManagementNurseNurse Based Care Management

This trial tests a new medical device that gives medication to patients in the intensive care unit (ICU). It aims to see if the device works safely and effectively.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
262 people
Ages
1 year and older
Study type
Interventional

Who can take part

  • You are currently in the intensive care unit (ICU).
  • You or your legal representative can sign a consent form agreeing to take part.
  • You do not have a bleeding disorder like hemophilia or a condition that affects how your blood clots.
  • You do not have an active infection at the device placement site or a serious body-wide infection.
  • You are able to understand and agree to participate in the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07587593Not yet recruiting
IVCare study for safer central line care

This study tests different ways to secure and care for central lines (special tubes that deliver medicine or fluids) to reduce infections and improve comfort. It may help find the best method for each patient.

NCT06828432Enrolling by invitation
Device study for heart surgery patients in the heart intensive care unit

This trial tests a new device that measures heart function closely after heart surgery. It may help doctors give better care if you are in the heart intensive care unit after your operation.

Pittsburgh, Pennsylvania
NCT06727240Recruiting
Safe infusion study for patients with IV lines

This trial tests a device or method to make IV infusions safer for patients who need fluids or medications through a tube in a vein. It's for adults who already have or will get an IV line for treatments lasting at least 15 minutes.

Coimbra
NCT06832722Recruiting· Phase 1/Phase 2
Study of a new drug for cardiogenic shock in intensive care

This trial tests an investigational drug called invobenitug for people in cardiogenic shock, a condition where the heart can't pump enough blood. The drug may help improve blood flow and reduce the need for strong blood pressure medicines.

Yerevan
NCT07009873Recruiting
Wearable ultrasound sensor trial for heart, leg, or ICU patients

This trial tests a wearable ultrasound sensor that can be stuck to the skin to monitor your heart, leg blood clots, or vital signs in the ICU. It may replace bulky machines and let doctors see your condition more easily and continuously.

Beijing, Beijing Municipality
NCT05471973Recruiting
Study for suspected heart device infection care improvement

This study is testing an approach to improve how clinicians care for people with suspected infections around an implanted heart device (like a pacemaker or defibrillator). It may help ensure the infection is recognized and treated appropriately, especially when device removal (extraction) might be needed.

Chicago, Illinois

Hear when a new Vascular Access trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.